AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-146768810/amazon-biotech-obtains-financing.html" title="Facts and information about Amazon Biotech obtains financing of $250,000 for Phase II HIV clinical trials.">Amazon Biotech obtains financing of $250,000 for Phase II HIV clinical trials.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Amazon Biotech obtains financing of $250,000 for Phase II HIV clinical trials.
(From Chemical Business NewsBase - Press Release)
Amazon Biotech Inc received $250,000 in funding for previously announced Phase II HIV clinical trials as well as an additional $350,000 in commitments for further funding. The company had previously announced that it has submitted to the FDA its protocol to test AMZ0026 as an antiviral and immuno-modulating agent in non-treated HIV subjects. The …
Related articles from newspapers, magazines, journals, and more
-
- Amazon Biotech Phase I/II HIV clinical trial protocol receives FDA "Green...
-
News wire article from: Chemical Business Newsbase
June 22, 2006
700+ words
-
- Amazon Biotech initiates negotiations subsequent to receiving "Go Ahead" from...
-
News wire article from: Chemical Business Newsbase
July 11, 2006
700+ words
